Open innovation in new drug research: the Indian perspective

Bhawani Bhatnagar, Viktor Dörfler, Jillian MacBryde

Research output: Contribution to conferencePaperpeer-review

187 Downloads (Pure)


This article sketches open innovation strategies pursued by eight Indian pharmaceutical firms and provides an account of strategic flexibility charted by firms in the wake of changes in the legislative environment. The findings examined through the lens of open innovation and dynamic capabilities identifies ‘technological competencies’ and ‘funding’ as two very important reasons, which push the traditionally closed R&D firms to pursue open innovation. Within the dynamic capabilities framework, the findings suggest that resources and competencies play a vital role in enabling open innovation in the complex new drug research setting.
Original languageEnglish
Publication statusPublished - 30 Jun 2015
Event22nd EurOMA 2015 - University of Neuchâtel, Neuchâtel, Switzerland
Duration: 26 Jun 20151 Jul 2015


Conference22nd EurOMA 2015


  • innovation strategies
  • open innovation
  • dynamic capabilities framework
  • pharmaceutical industry
  • India
  • drug research


Dive into the research topics of 'Open innovation in new drug research: the Indian perspective'. Together they form a unique fingerprint.

Cite this